Variant report
Variant | nsv821847 |
---|---|
Chromosome Location | chr2:186326466-186327516 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FSIP2-5 | chr2:186327396-186327672 | NONHSAT075962 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141368380 | chr2:186326475-186326476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534456170 | chr2:186326481-186326482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573267640 | chr2:186326522-186326523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377310388 | chr2:186326526-186326527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79576314 | chr2:186326540-186326541 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
6 | rs573861224 | chr2:186326711-186326712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75109151 | chr2:186326715-186326716 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
8 | rs147053284 | chr2:186326734-186326735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575031667 | chr2:186326861-186326862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs202077673 | chr2:186326863-186326864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561930330 | chr2:186326883-186326884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563516413 | chr2:186326890-186326891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541866858 | chr2:186326902-186326903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187825637 | chr2:186326921-186326922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141380265 | chr2:186326933-186326934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567947401 | chr2:186326936-186326937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12990307 | chr2:186326993-186326994 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs147698919 | chr2:186327061-186327062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540483479 | chr2:186327063-186327064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78156093 | chr2:186327067-186327068 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
21 | rs529073119 | chr2:186327087-186327088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35232204 | chr2:186327090-186327091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201960074 | chr2:186327162-186327163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550827103 | chr2:186327168-186327169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372519312 | chr2:186327190-186327191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192399996 | chr2:186327205-186327206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551585405 | chr2:186327224-186327225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566816626 | chr2:186327269-186327270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183879566 | chr2:186327280-186327281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571026226 | chr2:186327292-186327293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549236783 | chr2:186327297-186327298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12615022 | chr2:186327304-186327305 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs372753807 | chr2:186327309-186327310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538033635 | chr2:186327310-186327311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200335498 | chr2:186327316-186327317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576084791 | chr2:186327328-186327329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575517482 | chr2:186327339-186327340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368652623 | chr2:186327349-186327350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187696121 | chr2:186327367-186327368 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
40 | rs3054702 | chr2:186327384-186327385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201689242 | chr2:186327389-186327390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199956664 | chr2:186327390-186327391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2042508 | chr2:186327393-186327394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2042509 | chr2:186327394-186327395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs2113528 | chr2:186327401-186327402 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs2113527 | chr2:186327402-186327403 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs201401065 | chr2:186327403-186327404 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs545010084 | chr2:186327404-186327405 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs62198859 | chr2:186327413-186327414 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs28379193 | chr2:186327414-186327415 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186314400-186345200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr2:186317000-186337400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr2:186321400-186358600 | Weak transcription | HMEC | breast |
4 | chr2:186321800-186331200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |